PatientIQ 完成 3000 万美元融资，以扩展 EHR 集成的结局智能与 RWE
PatientIQ Closes $30M to Scale EHR-Integrated Outcomes Intelligence and RWE
你需要了解什么
医疗结局智能领导者 PatientIQ 已获得 3000 万美元 C 轮融资，由总部位于芝加哥的医疗健康私募股权公司 Hughes & Company 领投，Health Enterprise Partners 和 August Capital 继续提供支持。
自 2022 年完成 B 轮融资以来，PatientIQ 已将其 EHR 集成覆盖范围从 200 家扩展到 870 多家医疗服务提供机构，覆盖超过 1700 万名患者，并在 20 多个医学专科中采集了超过 7000 万个患者结局。
Hughes & Company 创始人兼管理合伙人 Travis Hughes 加入 PatientIQ 董事会。
通过云集成直接连接到 50 多个电子健康记录（EHR）平台——包括 Epic、Oracle Health（Cerner）和 athenahealth——将患者报告结局测量（PROMs）直接嵌入原生临床记录队列中。
在 870 个卫生系统中扩展自动化结局采集
自 2022 年完成 B 轮融资以来，PatientIQ 已将其企业覆盖范围从 200 家提供者组织扩展到 870 多个医疗系统、私人诊所和专科诊所。该平台目前覆盖全国超过 1700 万名患者，并已在 20 多个医学专科（包括骨科、神经外科和胸外科）中收集了超过 7000 万个患者结局。
PatientIQ 直接嵌入 50 多个 EHR 平台——包括 Epic、Oracle Health 和 athenahealth——在标准化的术前和术后临床时间点触发经过验证的调查采集，而无需临床医生退出其主要记录屏幕。
新资金将资助三项战略举措：
专科与注册登记深化：
扩展对大型卫生系统的整合，同时为主要专科机构的国家临床数据注册登记提供支持，包括 American Academy of Orthopaedic Surgeons（AAOS）、American Association of Neurological Surgeons（AANS）和 Society of Thoracic Surgeons（STS）。
生命科学真实世界证据（RWE）：
扩展其面向医疗器械和生物制药制造商的研究管线——包括 Johnson & Johnson 和 Zimmer Biomet 等企业客户——以支持上市后临床随访（PMCF）、FDA 监管提交和纵向比较有效性研究。
直接面向患者的商务：
建立一个市场层，旨在在患者的治疗后护理过程中，将患者直接连接到相关的康复工具、专科医疗用品和临床恢复服务。
What You Should Know
Healthcare outcomes intelligence leader PatientIQ has raised $30M in Series C financing led by Chicago-based healthcare private equity firm Hughes & Company, with continued backing from Health Enterprise Partners and August Capital Since completing its Series B round in 2022, PatientIQ has scaled its EHR-integrated footprint from 200 to more than 870 healthcare provider organizations, covering over 17 million patients and capturing more than 70 million patient outcomes across 20+ medical specialties.
Travis Hughes, Founder and Managing Partner of Hughes & Company, joins PatientIQ’s Board of Directors.
Connects directly via cloud integrations into more than 50 electronic health record (EHR) platforms—including Epic, Oracle Health (Cerner), and athenahealth—to embed patient-reported outcome measures (PROMs) directly into native clinical charting queues.
Scaling Automated Outcomes Capture Across 870 Health Systems
Since closing its Series B round in 2022, PatientIQ has expanded its enterprise footprint from 200 provider organizations to more than 870 healthcare systems, private practices, and specialty clinics. The platform now covers over 17 million patients nationwide and has collected more than 70 million patient outcomes across 20-plus medical specialties, including orthopedics, neurosurgery, and thoracic surgery.
PatientIQ embeds directly into more than 50 EHR platforms—including Epic, Oracle Health, and athenahealth—triggering validated survey collection at standardized pre- and post-operative clinical intervals without requiring clinicians to exit their primary charting screens.
The new capital will fund three strategic initiatives:
Specialty and Registry Deepening:
Expands integration across large health systems while powering national clinical data registries for major specialty bodies, including the American Academy of Orthopaedic Surgeons (AAOS), the American Association of Neurological Surgeons (AANS), and the Society of Thoracic Surgeons (STS).
Life Sciences Real-World Evidence (RWE):
Grows its research pipeline for medical device and biopharma manufacturers—including enterprise clients such as Johnson & Johnson and Zimmer Biomet—to support post-market clinical follow-up (PMCF), FDA regulatory submissions, and longitudinal comparative effectiveness studies.
Direct-to-Patient Commerce:
Establishes a marketplace layer designed to connect patients directly to relevant rehabilitation tools, specialty medical supplies, and clinical recovery services during their post-treatment care journeys.
Reader Interactions